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Abstract
Background: The relation between consumption of different types of dairy and risk of type 2 diabetes (T2D)
remains uncertain. Therefore, we aimed to evaluate the association between total dairy and individual types
of dairy consumptions and incident T2D in US adults.
Methods: We followed 41,436 men in the Health Professionals Follow-Up Study (1986 to 2010), 67,138 women in
the Nurses’ Health Study (1980 to 2010), and 85,884 women in the Nurses’ Health Study II (1991 to 2009). Diet was
assessed by validated food-frequency questionnaires, and data were updated every four years. Incident T2D was
confirmed by a validated supplementary questionnaire.
Results: During 3,984,203 person-years of follow-up, we documented 15,156 incident T2D cases. After adjustment
for age, body mass index (BMI) and other lifestyle and dietary risk factors, total dairy consumption was not
associated with T2D risk and the pooled hazard ratio (HR) (95% confidence interval (CI)) of T2D for one serving/day
increase in total dairy was 0.99 (0.98, 1.01). Among different types of dairy products, neither low-fat nor high-fat
dairy intake was appreciably associated with risk of T2D. However, yogurt intake was consistently and inversely
associated with T2D risk across the three cohorts with the pooled HR of 0.83 (0.75, 0.92) for one serving/day
increment (P for trend <0.001). We conducted a meta-analysis of 14 prospective cohorts with 459,790 participants
and 35,863 incident T2D cases; the pooled relative risks (RRs) (95% CIs) were 0.98 (0.96, 1.01) and 0.82 (0.70, 0.96) for
one serving total dairy/day and one serving yogurt/day, respectively.
Conclusions: Higher intake of yogurt is associated with a reduced risk of T2D, whereas other dairy foods and
consumption of total dairy are not appreciably associated with incidence of T2D.
Keywords: dairy, type 2 diabetes, cohort, meta-analysis
Background
Type 2 diabetes (T2D) affects approximately 26 million
people in the United States and 366 million people world-
wide, and the number will reach an estimated 552 million
worldwide by 2030 [1]. Further, management of diabetes
and its complications, such as cardiovascular disease,
imposes enormous medical and economic burdens [2].
Therefore, primary prevention of T2D has become a
public health imperative.
Because of their high content of calcium, magnesium,
vitamin D, whey protein and specific fatty acids, dairy
products have been suggested to lower risk of T2D [3].
Experimental studies indicated that whey protein has
insulinotropic and glucose-lowering properties [4]. Several
epidemiologic studies, but not all, have suggested that
dairy or calcium consumption was associated with lower
risks for hypertension and coronary artery disease [5]. On
the other hand, saturated fats in some dairy products
might offset the benefits of the potentially protective dairy
components [6], whereas other median chain satura-
ted and ruminant trans fatty acids could reduce risk [7].
Total dairy product intake was associated with marginally
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prospective cohort studies [8]. However, three large
Harvard cohorts, Health Professionals’ Follow-up Study
(HPFS), Nurses’ Health Study (NHS) and II, accounting
for 38% of participants included in the meta-analysis, have
accumulated up to 12 additional years of follow-up since
initial publications and the analyses have not been up-
dated. Furthermore, the meta-analysis has insufficient data
to evaluate most individual dairy subtypes robustly, espe-
cially yogurt, which has been linked to lower obesity and
may influence gut microbiota through probiotics [9]. In a
previous study [10], yogurt consumption was associated
with the least weight gain among all the food types in our
cohorts. To address these questions, we aimed to update
our previous analyses of total dairy and T2D risk with
longer duration of follow-up in the three large cohorts
and then assess subtypes of dairy consumption in detail.
We also conducted an updated meta-analysis of our re-
sults from these three cohorts and previous literature.
Methods
Study population
We used data from three prospective cohort studies:
HPFS, NHS and NHS II. The HPFS was composed of
51,529 US male dentists, pharmacists, veterinarians, op-
tometrists, osteopathic physicians and podiatrists, 40- to
75-years old, who returned a baseline questionnaire that
inquired about detailed medical history, as well as lifestyle
and usual diet in 1986. The NHS was initiated in 1976,
when 121,700 female registered nurses, 30- to 55-years
old, who lived in one of eleven states, completed a base-
line questionnaire about their lifestyle and medical history.
The NHS II was established in 1989 and consisted of
116,671 younger female registered nurses, 25- to 42-years
old, who responded to a baseline questionnaire similar to
the NHS questionnaire. Detailed descriptions of the three
cohorts have been published elsewhere [11-13]. In all
three cohorts, questionnaires were administered at base-
line and biennially thereafter, to collect and update infor-
mation on lifestyle practice and occurrence of chronic
diseases. The follow-up rates of the participants in these
cohorts were all >90%. In the current analysis, we exclu-
ded men and women who had diagnoses of diabetes
(including type 1 and type 2 diabetes and gestational dia-
betes only), cardiovascular disease, or cancer at baseline
(1986 for HPFS, 1980 for NHS, and 1991 for NHS II,
when we first assessed diet in these cohorts) [14]. In
addition, we excluded participants who left >70 of the 131
food items blank on the baseline food frequency question-
naire (FFQ) or who reported unusual total energy intakes
(that is, daily energy intake <800 or >4,200 kcal/day for
men and <500 or >3,500 kcal/day for women). We also
excluded participants without baseline information on
dairy consumption or follow-up information on diabetes
diagnosis date. After exclusions, data from 41,479 HPFS
participants, 67,138 NHS participants and 85,884 NHS II
participants were available for analysis. The study protocol
was approved by the institutional review boards of
Brigham and Women’s Hospital and Harvard School of
Public Health. The completion of the self-administered
questionnaire was considered to imply informed consent.
Assessment of dairy consumption
In 1980, a 61-item FFQ was administered to the NHS
participants to collect information on their usual intake
of foods and beverages in the previous year. In 1984,
1986, 1990, 1994, 1998 and 2002, similar but expanded
131-item FFQs were sent to these participants to update
their diet records. With the use of the expanded FFQ used
in the NHS, dietary data were collected in 1986, 1990,
1994, 1998 and 2002 from the HPFS participants, and in
1991, 1995, 1999 and 2003 from the NHS II participants.
In all FFQs, we asked the participants how often, on
average, they consumed each food of a standard portion
size. There were nine possible responses, which ranged
from ‘never or less than once per month’ to ‘6 or more
times per day’. Nutrient intake was calculated by multi-
plication of the frequency of consumption of each food
by the nutrient composition in the standard portion size
of that food and then summing up the nutrient intake
from all relevant food items. The food composition data-
base was created primarily from USDA sources [15].
Questionnaire items on dairy products included ‘skim/
low fat milk’,‘whole milk’,‘ice cream’,‘yogurt’,‘cottage/ri-
cotta cheese’,‘cream cheese’,‘other cheese’,‘cream’. From
1994 in NHS and HPFS and 1995 in NHS II, yogurt con-
sumption was separated into two items, ‘plain yogurt’
(plain or with NutraSweet) and ‘flavored yogurt’ (without
NutraSweet). The standard serving size was an 8 oz. glass
for skim, low fat milk, or whole milk, 1 Tbs for cream, sour
cream, ½ cup for sherbet or frozen yogurt, ice cream,
cottage or ricotta cheese, 1 oz. for cream cheese or other
cheese. The reproducibility and validity of these FFQs have
been shown in detail elsewhere [16-20]. The correlation
coefficients between FFQ and multiple dietary records were
0.62 both for low-fat dairy foods and for high-fat dairy
foods [20] and ranged from 0.57 for hard cheese to 0.97 for
yogurt regarding various dairy products intakes [16].
Assessment of covariates
In the biennial follow-up questionnaires, we inquired
about and updated information on risk factors for
chronic diseases, such as body weight, cigarette smoking,
physical activity, medication use and family history of
diabetes, as well as history of chronic diseases, including
hypertension and hypercholesterolemia. Among NHS and
II participants, we ascertained menopausal status, post-
menopausal hormone use and oral contraceptive use.
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A supplementary questionnaire about symptoms, diag-
nostic tests, and hypoglycemic therapy was mailed to
participants who reported that they had received a diagno-
sis of diabetes. In accordance with National Diabetes Data
Group criteria, a case of T2D was considered confirmed if
at least one of the following was reported on the supple-
mentary questionnaire [21]: 1) one or more classic symp-
toms (excessive thirst, polyuria, weight loss, hunger) and
fasting plasma glucose concentrations ≥7.8 mmol/L or
random plasma glucose concentrations ≥11.1 mmol/L;
2) ≥2 elevated plasma glucose concentrations on different
occasions (fasting concentrations ≥7.8 mmol/L, random
plasma glucose concentrations ≥11.1 mmol/L, and/or
concentrations of ≥11.1 mmol/L after ≥2 hours shown by
oral-glucose-tolerance testing) in the absence of symp-
toms; or 3) treatment with hypoglycemic medication
(insulin or oral hypoglycemic agent). The diagnostic cri-
teria were changed by the American Diabetes Association
in June 1998, and the threshold for the diagnosis of
diabetes became a fasting plasma glucose of 7.0 mmol/L,
instead of 7.8 mmol/L [22]. Only cases confirmed by the
supplemental questionnaires were included. The validity
of the supplementary questionnaire for the diagnosis of
diabetes has been documented previously. Of the 59 T2D
cases in HPFS and 62 cases in NHS who were confirmed
by the supplementary questionnaire, 57 (97%) and 61
(98%) were reconfirmed by medical records [23,24].
Deaths were identified by reports from next of kin or
postal authorities, or by searching the National Death
Index. At least 98% of deaths among the study partici-
pants were identified [10].
Statistical analysis
We calculated each individual’s person-years from the
date of return of the baseline questionnaire to the date
of diagnosis of T2D, death, or the end of the follow-up
(31 January 2010 for HPFS, 30 June 2010 for NHS or 30
June 2009 for NHS II), whichever came first. We used
time-dependent Cox proportional hazard regression to
estimate the hazard ratio (HR) for dairy consumption in
relation to the risk of T2D. Our basic model (Model 1)
simultaneously controlled for age, calendar time with
updated information at each two-year questionnaire
cycle, body mass index (BMI), and total energy intake.
Model 2 also adjusted for various potential confounding
factors, including race, smoking, physical activity, al-
cohol consumption, menopausal status and menopausal
hormone use (NHS and II participants only), oral contra-
ceptive use (NHS II participants only), family history of
diabetes and diagnosed hypertension or hypercholesterol-
emia at baseline. Model 3 further adjusted for trans-fat,
glycemic load, and intakes of red and processed meat,
nuts, sugar-sweetened beverages (SSBs) and coffee. For
individual dairy foods, we additionally adjusted for other
types of dairy in model 3.
We used the cumulative average of dietary intakes
from baseline to the censoring events in order to best
represent long-term diet and minimize within-person
variation [14]. In our primary analysis we stopped updat-
ing dietary intake when participants developed coronary
heart disease, stroke or cancer because changes in diet
after development of these conditions may confound the
relationship between diet and diabetes [14,25]. We con-
ducted a further analysis by stopping updating dietary
information after self-reported diagnosis of hypertension
and hypercholesterolemia during the follow-up because
these diagnoses appeared to alter consumption of dairy
products (see Results).
Proportional hazards assumption was tested with a
time dependent variable with the inclusion of an inter-
action term between the dairy intake and months to
events (P >0.05 for all tests). To test for linear trend, the
median value was assigned to each quintile and this
value was modeled as a continuous variable. All the ana-
lyses were conducted separately in each cohort, and we
also conducted meta-analyses to summarize the estimates
of association across the three studies. No significant het-
erogeneities were shown when the results were pooled
across the three cohorts; therefore, fixed-effect models
were used. All statistical tests were two-sided and per-
formed using SAS version 9.2 for UNIX (SAS Institute
Inc, Cary, NC, USA).
Updated meta-analysis on dairy products and risk of
incident T2D
We further conducted an updated meta-analysis that
incorporated our new results from the three cohorts into
the findings of previous studies. This meta-analysis was
conducted following a review protocol [26]. For study
selection, we included prospective studies with cohort,
case cohort or nested case-control design investigating
the association between intake of dairy products and risk
of T2D. The two recent meta-analyses involved a search
of the literature up to March 2013 [27] to June 2013 [8].
Thus, we conducted additional literature searches on
MEDLINE [28] and EMBASE [29] from June 2013 to
October 2013 [see Additional file 1]. In studies that re-
ported the intakes by grams, we used 177 g as a serving
size for total dairy products, and 244 g as a serving size
for milk and yogurt intake to recalculate the intakes to a
common scale (servings/day).
Results
We documented a total of 15,156 cases of incident
diabetes mellitus (DM), including 3,364 cases during a
maximum of 24 years of follow-up in the HPFS, 7,841
cases during a maximum of 30 years in the NHS, and
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a
HPFS (1986) NHS I (1980) NHS II (1991)
Characteristics Q1
(number =8,638)
Q3
(number =8,823)
Q5
(number =8,323)
Q1
(number =13,456)
Q3
(number= 13,397)
Q5
(number =13,433)
Q1
(number =17,225)
Q3
(number= 17,147)
Q5
(number =17,213)
Total dairy intake
(servings/day)
0.6 (0.4 to 0.7)
b 1.6 (1.4 to 1.7) 3.8 (3.4 to 4.6) 0.9 (0.7 to 1.1) 1.9 (1.8 to 2.0) 3.4 (3.1 to 3.8) 0.8 (0.5 to 1.1) 2.0 (1.7 to 2.3) 3.9 (3.4 to 4.8)
Age (years) 52.6(9.1)
c 52.9(9.5) 53.4(9.7) 46.4 (7.1) 46.1(7.1) 46.3(7.3) 36.8(4.6) 36.0(4.7) 35.2(4.6)
Physical activity
(MET-hours/week)
19.9(29.1) 21.6(28.0) 22.1(29.9) 12.3(17.5) 14.0(19.4) 15.4 (21.1) 19.0(27.2) 21.3(26.9) 22.7(28.6)
BMI (kg/m
2) 24.8(4.9) 25.0(4.8) 25.0(4.9) 24.0(4.3) 24.3(4.3) 24.3(4.4) 24.4(5.3) 24.6(5.3) 24.5(5.1)
Race, white (%) 91.7 96.0 97.0 95.8 98.5 98.9 93.0 97.6 97.9
Current smoker (%) 10.3 8.6 10.5 34.6 25.9 24.0 15.6 10.7 10.8
Hypertension (%) 21.0 19.6 17.4 16.4 14.7 13.7 6.5 6.0 5.2
High cholesterol (%) 12.6 10.0 8.2 6.1 4.7 4.8 16.0 13.6 12.6
Family history of
diabetes (%)
23.1 24.7 23.9 28.2 28.3 28.6 34.9 34.1 32.3
Postmenopausal (%) NA NA NA 32.1 31.2 31.3 3.55 2.99 2.72
Current menopausal
hormone use (%)
d
NA NA NA 21.6 22.1 21.6 83.1 80.9 83.8
Current oral conceptive
use (%)
NA NA NA NA NA NA 11.49 12.06 9.14
Total energy (Kcal/day) 1,657(523) 1,957(546) 2,425(626) 1,433(364) 1,699(363) 2,013(403) 1,443(475) 1,791(469) 2,180(514)
Alcohol (g/day) 12.3(16.6) 11.5(15.0) 10.4(15.0) 7.1(11.0) 6.1 (8.8) 5.2(8.0) 3.2(6.6) 3.4(6.0) 3.1(6.0)
Cereal fiber (g/day) 5.6(4.0) 6.0(3.8) 5.6(3.5) 4.5 (2.1) 5.0 (2.1) 4.8 (1.9) 5.4 (3.1) 5.8(3.0) 5.4(2.8)
Glycemic load 127(30) 125(24) 120(230) 103 (20) 103 (16) 101 (15) 127 (26) 121 (20) 115 (18)
Polyunsaturated to
saturated fat ratio
0.68(0.26) 0.56(0.17) 0.47(0.15) 0.59(0.18) 0.56 (0.14) 0.51 (0.13) 0.60(0.19) 0.52(0.13) 0.45(0.12)
Trans fat (% of total
energy)
2.8 (1.3) 2.9 (1.1) 2.8 (1.0) 1.8 (0.6) 1.7 (0.5) 1.7 (0.4) 1.8(0.7) 1.6(0.6) 1.5(0.5)
Fruit and vegetables
(servings/day)
4.9(2.8) 5.4(2.6) 5.8(2.9) 4.3 (1.9) 5.2 (1.9) 5.9 (2.1) 4.1(2.7) 5.2(2.7) 6.0(3.1)
Red and processed meat
intake (servings/day)
0.99(0.79) 1.16(0.79) 1.33(0.90) 1.02(0.60) 1.01 (0.51) 1.07 (0.56) 1.03(0.67) 1.17(0.68) 1.24(0.72)
Nuts intake
(servings/day)
0.38(0.54) 0.46(0.59) 0.58(0.73) 0.13 (0.18) 0.16(0.19) 0.19 (0.21) 0.07(0.20) 0.09(0.19) 0.10(0.22)
SSB intake (servings/day) 0.34(0.64) 0.36(0.58) 0.40(0.62) 0.33 (0.57) 0.27 (0.42) 0.29 (0.42) 0.54(0.99) 0.45(0.80) 0.45(0.77)
Coffee intake
(servings/day)
1.87(1.78) 1.92(1.75) 2.05(1.90) 2.08(1.57) 2.14 (1.42) 2.21 (1.50) 1.43 (1.71) 1.57(1.64) 1.70(1.74)
aData were age standardized except for age and dairy intake.
bMedian; interquartile range in parentheses (all such values).
cMean SD (all such values).
dCurrent menopausal hormone users among postmenopausal
women. HPFS, Health Professionals Follow-Up Study; METs, metabolic equivalent; NA, not available; NHS, Nurses’ Health Study; Q, quintile.
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53,951 cases during a maximum of 16 years in the NHS
II. For both men and women, total dairy intake was
inversely associated with smoking, hypertension and
hypercholesterolemia, but positively associated with phy-
sical activity, and fruit and vegetable intakes (Table 1).
Different types of dairy products were moderately cor-
related (Spearman correlation coefficients from -0.13 to
0.27 in the three cohorts).
Total dairy consumption was not associated with risk
of T2D in age- and multivariate-adjusted models across
the three cohorts (all P for trend >0.05), as shown in
Table 2. In the pooled analysis of estimates from the
three studies that used fixed-effect models, in the age-,
BMI- and energy-adjusted model, one serving/day incre-
ment of dairy consumption was significantly associated
with a 4% lower risk (95% confidence interval (CI): 2%,
6%); however, further adjustment for lifestyle and other
dietary factors attenuated the association to null with
the HR of a one serving/day increase of 0.99 (95% CI:
0.98, 1.01). The cohort-specific and combined spline ana-
lyses (Figure 1) based on multivariate models also indi-
cated a null association between total dairy consumption
Table 2 HRs (95% CI) of type 2 diabetes risk according to quintile of total dairy intake in HPFS, NHS I and NHS II
Frequency of consumption P-trend
b HR (95% CI) for
one serving/day Q1
a Q2
a Q3
a Q4
a Q5
a
HPFS
Daily servings (0.64, <0.86)
c (1.18, 0.86 to 1.34) (1.64, 1.35 to 1.90) (2.32, 1.91, 2.99) (3.59, ≥3.00)
Cases/person-years 660/161,017 698/157,956 654/159,981 669/160.184 683/159,307
Age-, BMI-and
energy-adjusted
d
1.0 1.06 (0.95, 1.18) 0.98 (0.87, 1.09) 0.97 (0.87, 1.09) 0.97 (0.87, 1.09) 0.34 0.98 (0.95, 1.01)
Adjusted for
non-dietary factors
d
1.0 1.10 (0.98, 1.22) 1.02 (0.92, 1.14) 1.00 (0.89, 1.12) 1.01 (0.90, 1.14) 0.60 0.99 (0.96, 1.02)
Adjusted for
dietary factors
d
1.0 1.08 (0.97, 1.21) 1.01 (0.91, 1.13) 0.99 (0.88, 1.11) 0.99 (0.88, 1.11) 0.38 0.98 (0.95, 1.01)
NHS
Daily servings (0.91, <1.20) (1.45, 1.20 to 1.66) (1.91, 1.67 to 2.15) (2.45, 2.16, 2.83) (3.37, ≥2.84)
Cases/person-years 1,596/350,963 1,575/350,493 1,531/351,353 1,584/350,639 1,555/351,058
Age-, BMI-and
energy-adjusted
1.00 0.93 (0.87, 1.00) 0.88 (0.82, 0.95) 0.90 (0.84, 0.97) 0.90 (0.83, 0.97) 0.01 0.97 (0.94, 0.99)
Adjusted for
non-dietary factors
1.00 0.97 (0.90, 1.04) 0.93 (0.86, 1.00) 0.94 (0.88, 1.02) 0.94 (0.87, 1.02) 0.13 0.98 (0.95, 1.00)
Adjusted for
dietary factors
1.00 1.00 (0.93, 1.07) 0.98 (0.91, 1.06) 1.03 (0.95, 1.11) 1.05 (0.97, 1.14) 0.15 1.02 (0.99, 1.05)
NHS II
Daily servings (0.79, <1.06) (1.40, 1.06 to 1.61) (1.96, 1.62 to 2.24) (2.71, 2.25, 3.02) (3.85, ≥3.03)
Cases/person-years 856/283,968 866/285,509 802/286,713 731/286,865 696/288,188
Age-, BMI-and
energy-adjusted
1.00 1.00 (0.91, 1.10) 0.92 (0.83, 1.01) 0.85 (0.77, 0.95) 0.83 (0.75, 0.92) <0.001 0.93 (0.90, 0.96)
Adjusted for
non-dietary factors
1.00 1.05 (0.96, 1.16) 1.01 (0.91, 1.11) 0.95 (0.86, 1.06) 0.94 (0.84, 1.04) 0.05 0.96 (0.94, 0.99)
Adjusted for
dietary factors
1.00 1.08 (0.98, 1.18) 1.04 (0.94, 1.15) 0.99 (0.89, 1.10) 1.00 (0.89, 1.11) 0.46 0.98 (0.95, 1.01)
Pooled analysis
Age-, BMI-and
energy-adjusted
1.00 0.98 (0.93, 1.03) 0.91 (0.86, 0.96) 0.90 (0.86, 0.95) 0.90 (0.85, 0.95) <0.001
e 0.96 (0.94, 0.98)
e
Adjusted for
non-dietary factors
1.00 1.02 (0.97, 1.07) 0.97 (0.92, 1.02) 0.96 (0.91, 1.01) 0.95 (0.90, 1.01) 0.02 0.98 (0.96, 0.99)
Adjusted for
dietary factors
1.00 1.04 (0.98, 1.09) 1.00 (0.95, 1.06) 1.01 (0.96, 1.07) 1.02 (0.96, 1.08) 0.99 0.99 (0.98, 1.01)
aQ is quintile;
bP-trend was calculated by assigning median values to each quintile and was treated as continuous variable;
cquintile median and cut-points in
parentheses (all such values);
dmodel was adjusted for age (continuous), BMI (eight categories), total energy intake (quintiles). Model 2 was additionally adjusted
for race, smoking, physical activity, alcohol consumption, menopausal status and menopausal hormone use (NHS I and II participants only), oral contraceptive use
(NHS II participants only), diabetes family history, hypertension, hypercholesterolemia. Model 3 was additionally adjusted for trans-fat intake, glycemic load, red
and processed meat intake, nuts intake, SSB intake, and coffee intake.
eP for heterogeneity <0.05. BMI, body mass index; CI, confidence interval; HPFS, Health
Professionals Follow-Up Study; HRs, hazard ratios; NHS, Nurses’ Health Study; Q, quintile.
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with age, BMI, vitamin D level, physical activity level
and diabetes family history were observed [see Additional
file 1: Table S1].
When we examined the association with dairy prod-
ucts categorized by their fat contents, there were no sig-
nificant associations between either low-fat or high-fat
dairy intake and risk of T2D (Table 3). The associations
between individual types of dairy products and risk of
T2D were further assessed, as shown in Table 4. All sub-
types of dairy products were mutually adjusted for each
other in the multivariate models. In the pooled analysis
of estimates from the three studies that used fixed-
effects models, each one serving/day increase of skim
milk, cheese and whole milk was associated with a 2%
(95% CI: -1%, 4%), 7% (95% CI: 3%, 11%) and 10% (95%
CI: 4%, 16%) higher risk of T2D, respectively (All P for
trend <0.05). Conversely, greater yogurt and ice cream
intakes were significantly associated with lower risk of
T2D with an HR of 0.83 (95% CI: 0.75, 0.92) and 0.78
(95% CI: 0.71, 0.86), respectively. No significant inter-
action of yogurt consumption with baseline BMI was ob-
served [see Additional file 1: Table S3]. In addition,
higher consumption of either plain (HR for each serving:
0.96, 95%CI: 0.88, 1.06) or flavored yogurt (HR: 0.88,
95%CI: 0.77, 1.01) was associated with a nonsignificantly
lower risk of T2D.
We conducted a further analysis by additionally stop-
ping updating dietary information after self-reported
diagnosis of hypertension or hypercholesterolemia dur-
ing the follow-up as the consumption of ice-cream was
decreased but consumption of skim milk was increased
after diagnosis of hypertension or hypercholesterolemia
in our three cohorts [see Additional file 1: Table S4]. As
shown in Table 5, the significant associations between
skim milk, cheese, whole milk and risk of T2D became
null, with the corresponding HRs of 1.01 (95%CI: 0.99,
1.03), 1.03 (95%CI: 0.99, 1.07) and 1.03 (95%CI: 0.99, 1.07),
respectively (all P-trend >0.05). The inverse association
between ice cream and T2D risk attenuated with an HR of
0.89 (95%CI: 0.83, 0.96), although still significant. On the
contrary, the inverse association between yogurt intake
and risk of T2D remained significant with an HR of 0.86
(95%CI: 0.78, 0.94) for one serving per day increment.
By incorporating our new results from the three cohorts
together with the findings of previous studies, we con-
ducted an updated meta-analysis. Our updated search
on MEDLINE and EMBASE found 513 potential cita-
tions, of which one study [30] met the inclusion criteria,
in addition to the citations in the two previous meta-
analyses. Therefore, a total of eleven prospective studies
[30-40] for total dairy and six [32-34,36-38] for yogurt
were included in our updated meta-analysis, along with
results from our current analysis. The characteristics of
the included studies are shown in Additional file 1:
Table S3. Total dairy intake was not significantly associ-
ated with risk of T2D whereas yogurt intake was associ-
ated with a significantly lower risk of T2D, as shown
in Figures 2 and 3. Significant heterogeneity was shown
for both total dairy (I
2 =58.8%; P = 0.003) and yogurt
(I
2 =63.2%; P = 0.005). The RRs (95% CIs) from the
random-effects model for one serving of total dairy intake
and one serving/day yogurt intake were 0.98 (0.96, 1.01)
and 0.82 (0.70, 0.96), respectively. The RRs (95% CIs) from
the fixed-effects model for one serving/day of total dairy
intake and one serving/day yogurt intake were 0.99 (0.98,
1.00) and 0.84 (0.78, 0.90), respectively.
After two studies [30,31] that did not adjust for total
energy intake and other main dietary confounders
were excluded, the heterogeneity for total dairy decreased
Figure 1 Dose-response relationship between total dairy intake and risk of type 2 diabetes in HPFS, NHS I and NHS II using multivariate
model. a) NHS. b) NHS II. c) HPFS. d) Pooled. HPFS, Health Professionals Follow-up Study; NHS, Nurses Health Study.
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Dairy intake (daily servings) HR (95% CI) for
one serving/day Variable Q1
a Q2
a Q3
a Q4
a Q5
a P-trend
b
Low-fat dairy intake
HPFS
Daily servings (0.07, <0.14)
c (0.43, 0.14 to 0.49) (0.86, 0.50 to 0.99) (1.28, 1.00 to 1.49) (2.57, ≥1.50)
Cases/person-years 709/154,402 681/161,216 666/163,722 663/159,761 645/159,343
Age-, BMI-and
energy-adjusted
d
1.00 0.93 (0.84, 1.04) 0.89 (0.80, 0.99) 0.92 (0.82, 1.02) 0.88 (0.79, 0.99) 0.06 0.97 (0.93, 1.00)
Unadjusted for
dietary factors
d
1.00 0.95 (0.85, 1.06) 0.92 (0.83, 1.02) 0.94 (0.84, 1.05) 0.90 (0.80, 1.00) 0.09 0.97 (0.93, 1.00)
Adjusted for
dietary factors
d
1.00 0.97 (0.87, 1.07) 0.95 (0.85, 1.06) 0.98 (0.88, 1.09) 0.95 (0.84, 1.06) 0.45 0.98 (0.95, 1.02)
NHS
Daily servings (0.23, <0.42) (0.64, 0.43 to 0.82) (1.03, 0.83 to 1.21) (1.50, 1.22 to 1.85) (2.42, ≥1.86)
Cases/person-years 1,652/351,416 1,504/350,553 1,620/350,912 1,479/350,718 1,586/350,907
Age-, BMI-and
energy-adjusted
1.00 0.89 (0.83, 0.96) 0.93 (0.87, 1.00) 0.84 (0.78, 0.90) 0.90 (0.84, 0.96) 0.004 0.96 (0.94, 0.99)
Unadjusted for
dietary factors
1.00 0.93 (0.87, 1.00) 0.97 (0.91, 1.04) 0.89 (0.83, 0.96) 0.93 (0.87, 1.00) 0.06 0.98 (0.95, 1.00)
Adjusted for
dietary factors
1.00 0.97 (0.91, 1.04) 1.03 (0.96, 1.10) 0.98 (0.91, 1.06) 1.05 (0.97, 1.14) 0.17 1.02 (0.99, 1.06)
NHS II
Daily servings (0.21, <0.34) (0.67, 0.35 to 0.87) (1.10, 0.88 to 1.21) (1.68, 1.22 to 2.01) (2.75, >2.02)
Cases/person-years 848/283,696 871/286,724 789/287,700 749/286,955 694/286,167
Age-, BMI-and
energy-adjusted
1.00 1.00 (0.91, 1.10) 0.90 (0.82, 0.99) 0.88 (0.79, 0.97) 0.82 (0.74, 0.91) <0.001 0.92 (0.89, 0.96)
Unadjusted for
dietary factors
1.00 1.05 (0.95, 1.15) 0.99 (0.89, 1.09) 0.96 (0.87, 1.06) 0.90 (0.81, 1.00) 0.01 0.95 (0.92, 0.99)
Adjusted for
dietary factors
1.00 1.07 (0.97, 1.17) 1.03 (0.93, 1.13) 1.01 (0.91, 1.12) 0.95 (0.85, 1.06) 0.13 0.97 (0.93, 1.01)
Pooled
Multivariate
RR (95% CI)
1.00 1.00 (0.95, 1.05) 1.01 (0.96, 1.06) 0.99 (0.94, 1.04) 1.00 (0.94, 1.05) 0.72 1.00 (0.98, 1.02)
e
High-fat dairy intake
HPFS
Daily servings (0.16, <0.28) (0.42, 0.28 to 0.49) (0.64, 0.50 to 0.72) (0.97, 0.73 to 1.14) (1.78, >1.15)
Cases/person-years 621/159,021 615/161,726 695/159,337 694/159,123 739/159,238
Age-, BMI-and
energy-adjusted
1.00 0.92 (0.82, 1.03) 1.02 (0.92, 1.14) 0.97 (0.86, 1.08) 1.04 (0.93, 1.16) 0.24 1.01 (0.96, 1.05)
Unadjusted for
dietary factors
1.00 0.95 (0.85, 1.06) 1.08 (0.96, 1.20) 1.03 (0.92, 1.15) 1.09 (0.98, 1.23) 0.05 1.02 (0.97, 1.06)
Adjusted for
dietary factors
1.00 0.90 (0.80, 1.01) 0.99 (0.88, 1.11) 0.94 (0.84, 1.05) 0.97 (0.86, 1.09) 0.87 0.98 (0.94, 1.03)
NHS
Daily servings (0.21, <0.31) (0.42, 0.32 to 0.50) (0.62, 0.51 to 0.73) (0.89, 0.74 to 1.10) (1.53, >1.11)
Cases/person-years 1,620/351,081 1,557/350,717 1,530/350,871 1,551/350,817 1,583/351,020
Age-, BMI-and
energy-adjusted
1.00 0.92 (0.86, 0.98) 0.89 (0.83, 0.96) 0.89 (0.82, 0.95) 0.96 (0.89, 1.04) 0.83 1.01 (0.97, 1.05)
Unadjusted for
dietary factors
1.00 0.95 (0.88, 1.02) 0.93 (0.86, 1.00) 0.92 (0.86, 0.99) 0.99 (0.92, 1.07) 0.80 1.01 (0.97, 1.05)
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2=35 .6 %; P = 0.11); additionally, heterogeneity for
yogurt was reduced when one study [36] was removed
(I
2=40 .7 %;P = 0.063). Both exclusions did not change the
summary RRs materially. On the basis of a funnel plot
[see Additional file 1: Figure S2] and Begg’s test, no signi-
ficant publication bias was shown for the association
between total dairy (P = 0.19) or yogurt (P =0 . 9 2 )i n t a k e
and risk of T2D.
We also classified studies according to duration of follow-
up as short-term (≤10 years) or long-term (>10 years). Total
dairy consumption was marginally significantly associ-
ated with a lower T2D risk in the short-term studies
(RR: 0.95, 95%CI: 0.91, 1.00) but not in the long-term
studies (RR: 1.00, 95%CI: 0.98, 1.02). Yogurt consump-
tion was associated with a lower T2D risk in both short-
term (RR: 0.86, 95%CI: 0.69, 1.08) and long-term studies
(RR: 0.76, 95%CI: 0.58, 0.98).
Discussion
In three prospective cohorts of US men and women, we
found that intakes of total dairy products were not sig-
nificantly associated with the risk of T2D, but higher
consumption of yogurt was significantly associated with
a lower risk. An updated meta-analysis of our cohorts
and published literature suggest a marginally lower risk
of T2D with higher dairy consumption and a consistent
inverse association between yogurt consumption and
T2D risk.
Dairy is a complex food with many bioactive compounds
that have divergent health effects, and its association with
T2D has attracted much attention [5]. Our results on
total dairy intake and T2D risk are consistent with some
[33,34,36,37,40], but not all previous studies. Total dairy
consumption was associated with a lower risk of T2D in
our earlier investigations in HPFS [11] and NHS [12],
but not in NHS II [13]. The reason for the discrepancy
between our earlier and current results is probably due
to longer follow-up (10 more years) of the NHS and
HPFS cohorts, and our meta-analysis suggests that
potential benefits of dairy were less evident with long-
term follow-up. For yogurt consumption, we observed a
consistent and robust inverse association with T2D in our
cohorts and the meta-analysis. A previous meta-analysis
[8] reported a similar but nonsignificant risk estimate
of development of T2D associated with 200 g yogurt
consumption with an RR of 0.78 (95%CI: 0.60, 1.02).
Our updated meta-analysis suggested that each one
serving/day yogurt increase was significantly associated
with a 18% lower risk. Surprisingly, consumption of ice
cream was inversely associated with T2D risk whereas
skim milk was associated with higher T2D risk; however,
these associations either became null or attenuated in
further analysis when we stopped updating dietary infor-
mation after self-reported diagnosis of hypertension
or hypercholesterolemia during the follow-up. Since con-
sumption of ice cream was decreased but consumption of
skim milk was increased after diagnosis of hypertension or
hypercholesterolemia in our three cohorts [see Additional
file 1: Table S4], reverse causation may explain the find-
ings that did not take into account changes in diet after
diagnosis of these conditions.
Certain components in dairy products, such as calcium,
v i t a m i nD ,m a g n e s i u m ,l a c t o s ea n dd a i r yp r o t e i n ,h a v eb e e n
suggested to have a favorable impact on metabolic factors,
including body weight, hypertension [41,42] and glucose
homeostasis [43]. Calcium supplement has been showed to
have a small but significant reduction in body weight over a
placebo in a recent meta-analysis [44] of seven trials, but
Table 3 Relative risk (RR) of type 2 diabetes among men according to low-fat versus high-fat dairy food intake (Continued)
Adjusted for
dietary factors
1.00 0.95 (0.89, 1.02) 0.93 (0.86, 1.00) 0.92 (0.85, 0.99) 1.01 (0.93, 1.09) 0.51 1.03 (0.99, 1.07)
NHS II
Daily servings (0.20, <0.28) (0.43, 0.29 to 0.52) (0.64, 0.53 to 0.77) (0.98, 0.78 to 1.17) (1.71, >1.18)
Cases/person-years 792/289,456 775/274,246 843/293,070 811/286,254 730/288,217
Age-, BMI-and
energy-adjusted
1.00 0.95 (0.86, 1.05) 1.01 (0.91, 1.11) 1.01 (0.91, 1.12) 0.94 (0.85, 1.05) 0.40 0.96 (0.92, 1.01)
Unadjusted for
dietary factors
1.00 0.98 (0.89, 1.09) 1.07 (0.97, 1.19) 1.09 (0.98, 1.20) 1.02 (0.92, 1.14) 0.49 0.99 (0.94, 1.03)
Adjusted for
dietary factors
1.00 0.97 (0.88, 1.07) 1.05 (0.95, 1.16) 1.07 (0.96, 1.18) 1.03 (0.92, 1.15) 0.35 1.00 (0.95, 1.05)
Pooled
Multivariate Model 1.00 0.94 (0.90, 0.99) 0.97 (0.92, 1.02) 0.96 (0.91, 1.01) 1.00 (0.95, 1.06) 0.30 1.01 (0.98, 1.03)
aQ is quintile;
bP-trend was calculated by assigning median values to each quintile and was treated as continuous variable;
cquintile median and cut-points in
parentheses (all such values);
dModel 1 was adjusted for age (continuous), BMI (eight categories), total energy intake (quintiles). Model 2 was additionally adjusted
for race, smoking, physical activity, alcohol consumption, menopausal status and menopausal hormone use (NHS I and II participants only), oral contraceptive use
(NHS II participants only), diabetes family history, hypertension, hypercholesterolemia. Model 3 was additionally adjusted for trans-fat intake, glycemic load, red
and processed meat intake, nuts intake, SSB intake, and coffee intake.
eP for heterogeneity <0.05. BMI, body mass index; CI, confidence interval; HPFS, Health
Professionals Follow-up Study; NHS, Nurses Health Study.
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Dairy intake (servings) P for trend
a HR (95% CI) for
one serving/day Variable Category 1 Category 2 Category 3 Category 4
Skim/low-fat milk <1/week 1 to 4/week 5/week to 1.4/day ≥1.5/day
HPFS 0/week
c 2.3/week 0.9/day 2.5/day
Cases/person-years 800/187,455 878/211,190 1,095/263,155 591/136,644
Multivariate model
b 1.00 1.01 (0.91, 1.11) 1.05 (0.96, 1.16) 1.05 (0.94, 1.18) 0.35 0.99 (0.96, 1.03)
NHS 0.2/week 2.6/week 1.0/day 2.4/day
Cases/person-years 1,434/324,753 2,022/478,343 2,932/652,108 1,453/299,303
Multivariate model 1.00 1.00 (0.93, 1.08) 1.05 (0.98, 1.12) 1.13 (1.04, 1.23) <0.001 1.06 (1.02, 1.09)
NHS II 0.2/week 3.0/week 1.0/day 2.5/day
Cases/person-years 629/222,580 1,181/414,562 1,490/521.220 651/272,879
Multivariate model 1.00 1.05 (0.95, 1.16) 1.15 (1.04, 1.27) 1.02 (0.91, 1.15) 0.92 0.97 (0.93, 1.01)
Pooled
Multivariate model 1.00 1.02 (0.97, 1.07) 1.07 (1.02, 1.12) 1.08 (1.02, 1.15) 0.006
d 1.02 (0.99, 1.04)
d
Cheese intake <1/week 1 to 4/week 5/week to 1.4/day ≥1.5/day
HPFS 0.6/week 2.6/week 0.8/day 1.8/day
Cases/person-years 407/110,338 1,658/415,482 1,167/250,081 132/22,544
Multivariate Model 1.00 1.07 (0.96, 1.20) 1.16 (1.02, 1.31) 1.31 (1.07, 1.62) 0.002 1.07 (0.99, 1.15)
NHS 0.7/week 2.6/week 0.8/day 2.3/day
Cases/person-years 850/166,664 4,223/990,161 2,623/568,288 145/29,393
Multivariate Model 1.00 0.95 (0.90, 0.99) 1.00 (0.97, 1.04) 1.06 (0.90, 1.26) 0.09 1.09 (1.02, 1.17)
NHS II 0.7/week 2.6/week 0.8/day 1.7/day
Cases/person-years 364/118,132 1,964/751,355 1,499/520,280 124/41,475
Multivariate Model 1.00 0.90 (0.80, 1.02) 0.97 (0.85, 1.10) 0.89 (0.72, 1.10) 0.80 1.04 (0.96, 1.12)
Pooled
Multivariate Model 1.00 0.96 (0.92, 1.00)
d 1.01 (0.98, 1.05)
d 1.08 (0.96, 1.20)
d 0.004 1.07 (1.03, 1.11)
Yogurt <1/month 1 to 3/month 1/week ≥2/week
HPFS 0/month 2.1/month 1.0/week 3.0/week
Cases/person-years 1,894/413,496 669/160,207 485/134,656 316/90,085
Multivariate model 1.00 0.97 (0.88, 1.06) 0.89 (0.80, 0.99) 0.95 (0.84, 1.08) 0.30 0.85 (0.68, 1.06)
NHS 0/month 1.8/month 1.2/week 2.9/week
Cases/person-years 3,118/608,342 1,762/360,994 1,930/476,985 1,031/308,184
Multivariate model 1.00 1.02 (0.96, 1.08) 0.91 (0.85, 0.97) 0.84 (0.78, 0.91) <0.001 0.75 (0.65, 0.86)
NHS II 0/month 2.1/month 1.0/week 2.7/week
Cases/person-years 1,153/354,086 867/299,194 1,174/438,017 757/339,945
Multivariate model 1.00 1.00 (0.91, 1.09) 1.00 (0.91, 1.09) 0.90 (0.81, 1.00) 0.02 0.94 (0.80, 1.10)
Pooled
Multivariate model 1.00 1.00 (0.96, 1.05) 0.93 (0.89, 0.97) 0.88 (0.83, 0.93) <0.001 0.83 (0.75, 0.92)
Whole milk <1/month 1 to 3/month 1/week ≥2/week
HPFS 0/month 2.1/month 1.5/week 5.2/week
Cases/person-years 2,492/606,198 323/70,991 215/51,858 334/69,398
Multivariate model 1.00 1.05 (0.93, 1.18) 0.96 (0.83, 1.11) 1.11 (0.98, 1.25) 0.13 1.07 (0.98, 1.17)
NHS 0/month 1.5/month 1.05/week 3.5/week
Cases/person-years 4,736/107,7815 959/207,604 1,091/245,503 1,055/223,583
Multivariate model 1.00 1.01 (0.94, 1.09) 0.99 (0.93, 1.06) 1.08 (1.00, 1.15) 0.05 1.14 (1.06, 1.23)
NHS II 0/month 2.1/month 1.5/week 4.7/week
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(Continued)
Cases/person-years 3,373/122,3599 242/84,815 190/66,854 146/55,973
Multivariate model 1.00 0.96 (0.84, 1.09) 1.04 (0.90, 1.21) 1.03 (0.87, 1.22) 0.65 0.98 (0.83, 1.14)
Pooled
Multivariate model 1.00 1.01 (0.96, 1.07) 1.00 (0.94, 1.05) 1.08 (1.02, 1.14) 0.02 1.10 (1.04, 1.16)
Ice Cream <1/month 1 to 3/month 1/week ≥2/week
HPFS 0/month 2.1/month 1.0/week 3.0/week
Cases/person-years 778/165,934 1,262/287,954 851/218,100 473/126,457
Multivariate RR (95% CI) 1.00 0.83 (0.75, 0.91) 0.68 (0.62, 0.76) 0.63 (0.56, 0.71) <0.001 0.84 (0.71, 0.99)
NHS 0.6/month 1.8/month 1.1/week 2.8/week
Cases/person-years 1,282/286,271 2,822/626,515 2,518/570,309 1,219/271,411
Multivariate RR (95% CI) 1.00 0.90 (0.84, 0.96) 0.83 (0.78, 0.89) 0.79 (0.72, 0.86) <0.001 0.71 (0.62, 0.82)
NHS II 0/month 2.1/month 1.1/week 3.0/week
Cases/person-years 1,185/436,526 1,679/598,547 830/306,473 257/89,696
Multivariate RR (95% CI) 1.00 0.88 (0.82, 0.95) 0.77 (0.70, 0.84) 0.79 (0.69, 0.91) <0.001 0.90 (0.73, 1.12)
Pooled
Multivariate RR (95% CI) 1.00 0.87 (0.84, 0.91) 0.78 (0.74, 0.82)
d 0.74 (0.70, 0.79)
d <0.001
d 0.78 (0.71, 0.86)
Cream <1/month 1 to 3/month 1/week ≥2/week
HPFS 0/month 1.5/month 1.0/week 4.5/week
Cases/person-years 2,145/501,934 509/127,177 261/66,686 449/102,648
Multivariate model 1.00 0.95 (0.86, 1.05) 0.94 (0.82, 1.07) 0.98 (0.88, 1.09) 0.84 0.94 (0.87, 1.02)
NHS 0/month 1.8/month 1.1/week 4.8/week
Cases/person-years 4,271/822,910 1,257/269,337 820/178,495 956/212,976
Multivariate model 1.00 0.96 (0.90, 1.03) 0.92 (0.85, 0.99) 0.99 (0.92, 1.07) 0.92 1.01 (0.95, 1.07)
NHS II 0/month 1.5/month 0.7/week 3.5/week
Cases/person-years 1,703/590,798 874/305,399 618/215,329 756/319,716
Multivariate model 1.00 1.00 (0.92, 1.09) 1.02 (0.93, 1.13) 1.04 (0.94, 1.14) 0.46 1.02 (0.95, 1.09)
Pooled
Multivariate model 1.00 0.97 (0.93, 1.02) 0.95 (0.90, 1.01) 1.00 (0.95, 1.05) 0.88 0.99 (0.95, 1.03)
Sherbet <1/month 1-3/month 1/week ≥2/week
HPFS 0/month 1.8/month 1.0/week 2.4/week
Cases/person-years 1,386/325,655 1,050/251,524 558/136,755 370/84,511
Multivariate model 1.00 1.01 (0.93, 1.10) 1.05 (0.94, 1.17) 1.09 (0.97, 1.23) 0.13 0.98 (0.80, 1.21)
NHS 0.1/month 1.8/month 1.1/week 2.8/week
Cases/person-years 3,052/609,546 2,081/402,796 1,576/335,068 595/136,309
Multivariate model 1.00 1.06 (1.00, 1.13) 1.02 (0.95, 1.09) 1.00 (0.91, 1.10) 0.79 0.96 (0.82, 1.12)
NHS II 0/month 2.1/month 1.3/week 3.0/week
Cases/person-years 1,292/501,292 1,413/499,003 946/321,704 300/109,243
Multivariate model 1.00 1.03 (0.95, 1.11) 1.00 (0.92, 1.10) 0.93 (0.81, 1.06) 0.24 0.94 (0.78, 1.14)
Pooled
Multivariate model 1.00 1.04 (1.00, 1.09) 1.02 (0.97, 1.07) 1.01 (0.94, 1.07) 0.88 0.96 (0.87, 1.07)
aP-trend was calculated by assigning median values to each quintile and was treated as continuous variable;
bmultivariate model was adjusted for age
(continuous), BMI (eight categories), total energy intake (quintiles), race, smoking, physical activity, alcohol consumption, menopausal status and menopausal
hormone use (NHS I and II participants only), oral contraceptive use (NHS II participants only), diabetes family history, hypertension, hypercholesterolemia, trans-fat
intake, glycemic load, red and processed meat intake, nuts intake, SSB intake, and coffee intake, and other dairy types for individual dairy types;
ccategory median intake
(all such values);
dP for heterogeneity <0.05. CI, confidence interval; HPFS, Health Professionals Follow-up Study; HR, hazard ratio; NHS, Nurses Health Study.
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find a significant effect of two-year calcium supplement use
compared to the placebo. Conjugated linoleic acid, created
by bacteria in the gut of ruminants, has been shown to
reduce body weight in animals [46]. However, findings
from randomized trials did not provide clear support
for a role of dairy products in weight reduction [47].
Milk proteins, such as whey, may have insulinotropic
properties with a relatively low glycemic load (GL), which
may improve glucose tolerance [48]. Circulating trans-
palmitoleate concentrations [7] have been inversely associ-
ated with insulin resistance, atherogenic dyslipidemia and
incident diabetes. Whole-fat dairy product consumption
was strongly associated with higher trans-palmitoleate
which may offset the unfavorable effect of saturated fat in
high-fat dairy product intake.
Several mechanisms may explain the inverse associ-
ation between yogurt intake and risk of T2D. Probiotic
bacteria have been shown to improve lipid profile and
antioxidant status in T2D patients [49,50] and have bene-
ficial effects on cholesterol levels [51]. In addition, our
previous study [10] of the three cohorts showed that in-
creased consumption of yogurt was inversely associated
with weight gain. However, adjusting for BMI in the multi-
variate model did not alter the inverse association between
yogurt intake and T2D risk.
The strengths of the current study include a large sam-
ple size, high rates of follow-up and repeated assessments
of dietary and lifestyle variables. The current study was
subject to several limitations as well. First, our study
populations primarily consisted of health professionals of
European ancestry. Although the homogeneity of socio-
economic status helps reduce confounding, the observed
associations may not be generalizable to other popula-
tions. However, the relatively high educational status is
an advantage because high quality and reliable data can
be collected from our study participants. Second, be-
cause diet was assessed by FFQs, some measurement
error of dairy intake assessment is inevitable. However,
the FFQs used in these studies were validated against
multiple diet records, and reasonable correlation coeffi-
cients between these assessments of dairy intake were
Table 5 Multivariate relative risk (RR) of type 2 diabetes among men and women according to specific dairy foods
using different methods of updating diets
Dairy Intake (servings) P for trend
a HR (95% CI) for
one serving/day Variable Category 1 Category 2 Category 3 Category 4
Skim/low-fat milk <1/week 1 to 4/week 5/week to 1.4/day ≥1.5/day
Direct update
b 1.00 1.11 (1.05, 1.17) 1.16 (1.10, 1.22) 1.19 (1.12, 1.26) <0.001 1.02 (1.00, 1.05)
Stop updating CVD and cancer 1.00 1.02 (0.97, 1.07) 1.07 (1.02, 1.12) 1.08 (1.02, 1.15) 0.006 1.02 (0.99, 1.04)
Stop updating+ HTHC
c 1.00 0.94 (0.90, 0.99) 0.97 (0.93, 1.01) 1.02 (0.97, 1.07) 0.25 1.01 (0.99, 1.03)
Cheese intake <1/week 1 to 4/week 5/week to 1.4/day ≥1.5/day
Direct update 1.00 0.97 (0.93, 1.01) 1.07 (1.03, 1.12) 1.19 (1.06, 1.33) <0.001 1.10 (1.05, 1.14)
Stop updating CVD and cancer 1.00 0.96 (0.92, 1.00) 1.01 (0.98, 1.05) 1.08 (0.96, 1.20) 0.004 1.07 (1.03, 1.11)
Stop updating+ HTHC 1.00 0.96 (0.92, 1.00) 1.00 (0.98, 1.03) 1.02 (0.92, 1.13) 0.41 1.03 (0.99, 1.07)
Yogurt <1/month 1 to 3/month 1/week ≥2/week
Direct update 1.00 1.01 (0.97, 1.06) 0.96 (0.92, 1.01) 0.91 (0.86, 0.96) <0.001 0.83 (0.76, 0.92)
Stop updating CVD and cancer 1.00 1.00 (0.96, 1.05) 0.93 (0.89, 0.97) 0.88 (0.83, 0.93) <0.001 0.83 (0.75, 0.92)
Stop updating+ HTHC 1.00 0.97 (0.93, 1.02) 0.92 (0.88, 0.97) 0.87 (0.82, 0.91) <0.001 0.86 (0.78, 0.94)
Ice cream <1/month 1 to 3/month 1/week ≥2/week
Direct update 1.00 0.85 (0.82, 0.89) 0.77 (0.73, 0.81) 0.68 (0.63, 0.72) <0.001 0.73 (0.66, 0.81)
Stop updating CVD and cancer 1.00 0.87 (0.84, 0.91) 0.78 (0.74, 0.82) 0.74 (0.70, 0.79) <0.001 0.78 (0.71, 0.86)
Stop updating+ HTHC 1.00 0.96 (0.92, 1.00) 0.89 (0.85, 0.94) 0.89 (0.84, 0.94) <0.001 0.89 (0.83, 0.96)
Whole milk <1/month 1 to 3/month 1/week ≥2/week
Direct update 1.00 1.03 (0.98, 1.10) 0.99 (0.94, 1.05) 1.12 (1.05, 1.19) <0.001 1.10 (1.03, 1.17)
Stop updating CVD and cancer 1.00 1.01 (0.96, 1.07) 1.00 (0.94, 1.05) 1.08 (1.02, 1.14) 0.02 1.10 (1.04, 1.16)
Stop updating+ HTHC 1.00 0.96 (0.90, 1.01) 1.04 (0.98, 1.11) 1.03 (0.98, 1.08) 0.15 1.03 (0.99, 1.07)
aP-trend was calculated by assigning median values to each quintile and was treated as continuous variable;
bdirect update: cumulative averages of dairy intakes
were calculated without stopping updating diets. All multivariate models were adjusted for age (continuous), BMI (eight categories), total energy intake (quintiles),
smoking, physical activity, alcohol consumption, menopausal status, race, diabetes family history, baseline hypertension, hypercholesterolemia, trans-fat intake,
glycemic load, red and processed meat intake, nuts intake, SSB intake, and coffee intake, and other dairy types for individual dairy types;
cHTHC: hypertension and
hypercholesterolemia. BMI, body mass index; CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; SSB, sugar-sweetened beverages.
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for dietary variables to minimize the random measure-
ment error caused by within-person variation and to ac-
commodate diet changes over time. Nonetheless, since
we did not specifically assess types or brands of yogurt
consumed by the participants, it is difficult to attribute
the observed benefits to various components of yogurt.
Lastly, because of the observational nature of our co-
horts, the observed associations do not necessarily mean
causation; although we adjusted for established and
Figure 3 HRs for a serving yogurt consumption per day and type 2 diabetes. T h eR Ro fe a c hs t u d yi sr e p r e s e n t e db yas q u a r e ,a n dt h es i z eo f
the square represents the weight of each study of the overall estimate. The 95% CIs are represented by the horizontal lines, and the diamond represents
the overall estimate and its 95% CI. HPFS, Health Professional Follow-Up Study; NHS, Nurses’ Health Study. CI, confidence interval; HRs, hazard ratios; RR,
relative risk.
Figure 2 HRs for a serving total dairy consumption per day and type 2 diabetes. The RR of each study is represented by a square, and the
size of the square represents the weight of each study of the overall estimate. The 95% CIs are represented by the horizontal lines, and the diamond
represents the overall estimate and its 95% CI. HPFS, Health Professional Follow-Up Study; NHS, Nurses’ Health Study. CI, confidence interval; HRs,
hazard ratios; RR; relative risk.
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confounding is still possible. This is especially true for
yogurt consumption, which is typically associated with a
healthy diet and lifestyle.
Conclusions
We found that higher intake of yogurt is associated with
a reduced risk of T2D, whereas other dairy foods and
consumption of total dairy are not appreciably associ-
ated with incidence of T2D. The consistent findings for
yogurt suggest that it can be incorporated into a healthy
dietary pattern. However, randomized clinical trials are
warranted to further examine the causal effects of yogurt
consumption as well as probiotics on body weight and
insulin resistance.
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